Viracta Therapeutics Inc. buy me8
Start price
23.02.21
/
0%
€15.09
Target price
23.02.22
-
Performance (%)
18.33%
End price
24.02.21
€17.85
Summary
This prediction ended on 24.02.21 with a price of €17.85. The prediction had a final performance of 18.33%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Viracta Therapeutics Inc. | 6.316% | 6.316% | -76.374% | -96.849% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% | 25.039% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% | 48.139% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% | 11.979% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% | 46.982% |
According to me8 what are the pros and cons of Viracta Therapeutics Inc. for the foreseeable future?
Pros
Innovative
Could be worthwhile Investment >10% per year
Good culture
Cons
No uniques
Comments by me8 for this prediction
In the thread Sunesis Pharmaceuticals diskutieren
Buy Sunesis Pharmaceuticals Inc.
In the thread Trading Sunesis Pharmaceuticals
Buy beendet
Stopped prediction by me8 for Viracta Therapeutics Inc.
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.65
30.11.20
30.11.20
€10.50
30.11.21
30.11.21
-21.05%
14.12.20
14.12.20
Innovative
Could be worthwhile Investment >10% per year
Good culture
No uniques